<DOC>
	<DOCNO>NCT02456025</DOCNO>
	<brief_summary>The main aim study evaluate efficacy safety topical tacrolimus 0.01 % eyedrops patient vernal keratoconjunctivitis .</brief_summary>
	<brief_title>Topical Tacrolimus Vernal Keratoconjunctivitis</brief_title>
	<detailed_description>A total 20 patient bilateral symmetrical vernal keratoconjunctivitis include . Each patient undergo complete ophthalmologic evaluation . Patient place random topical Tacrolimus 0.01 % ophthalmic solution one eye placebo eyedrops fellow eye . Patients undergo ophthalmologic examination one week one month . Photos take . The outcome measure include grade symptom , grade sign , laboratory investigation . Symptoms itching , redness , foreign body sensation , tear discharge follow record treatment . The grade clinical sign conjunctival hyperemia , conjunctival papillary hypertrophy , perilimbal infiltrates , Trantas dot , superficial punctate keratopathy record treatment . Conjunctival surface temperature determine treatment . Conjunctival scraping stain Giemsa assess therapy number eosinophil per hpf determine record .</detailed_description>
	<mesh_term>Keratoconjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis , Allergic</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>bilateral symmetrical palpebral limbal vernal keratoconjunctivitis Patients 618 year age Pregnant patient Patients systemic therapy allergic disorder Patients come followup Patients topical medication comorbid ocular condition</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>